Economic assessment of implementing Hexaxim® vaccine within the South African Expanded Programme on Immunisation (EPI-SA)
Main Authors: | M. Mogale, R.J. Burnett, D. Olivier, J. Mphahlele |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-04-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971214013666 |
Similar Items
-
Designing the Expanded Programme on Immunisation (EPI) as a service: Prioritising patients over administrative logic
by: McKnight, J, et al.
Published: (2014) -
DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
by: Florence Boisnard, et al.
Published: (2023-12-01) -
Impact of Expanded Programme on Immunization (EPI) on Rates and Trends in Admission of Neonatal Tetanus and Measles
by: Oruamabo RS, et al.
Published: (2024-06-01) -
Evaluating the functionality and effectiveness of ZITAG and related expanded programme on immunisation technical committees in Zambia
by: Moses C. Simuyemba, et al.
Published: (2022-12-01) -
Getting it right—the Australian Childhood Immunisation Register and immunisation rates in south‐eastern Sydney
by: Susan J. Botham, et al.
Published: (2004-02-01)